Homocysteine Modulates the CD40/CD40L System

Journal of the American College of Cardiology

Volumn 49, Issue 22, 2007, Pages 2182-2190

  Prontera, Cesaria ^a   Martelli, Nicola ^b   Evangelista, Virgilio ^b   D'Urbano, Etrusca ^a   Manarini, Stefano ^b   Recchiuti, Antonio ^a   Dragani, Alfredo ^c   Passeri, Cecilia ^c   Davì, Giovanni ^a   Romano, Mario ^b  

^a UNIVERSITY OF CHIETI   (Italy)

^b Consorzio Mario Negri Sud ^*  (Italy)

^c Civil Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CD40 ANTIGEN; CD40 LIGAND; CYSTEINE; HOMOCYSTEINE; HYDROGEN PEROXIDE; MESSENGER RNA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENOTYPE; HUMAN; HUMAN CELL; HYPERHOMOCYSTEINEMIA; HYPERTENSION; INCIDENCE; KIDNEY DISEASE; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SMOKING; STATISTICAL ANALYSIS; THROMBOCYTE; THROMBOSIS; WESTERN BLOTTING;

ADULT; ANTIGENS, CD40; BLOOD PLATELETS; CD40 LIGAND; ENDOTHELIAL CELLS; FEMALE; HOMOCYSTEINE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 34249706257     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.02.044     Document Type: Article

References (32)

1. Clarke R., Daly L., Robinson K., et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324 (1991) 1149-1155
2. Austin R.C., Lentz S.R., and Werstuck G.H. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ 11 (2004) S56-S64
3. Mach F., Schonbeck U., Sukhova G.K., et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci U S A 94 (1997) 1931-1936
4. Henn V., Slupsky J.R., Grafe M., et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391 (1998) 591-594
5. Dechanet J., Grosset C., Taupin J.L., et al. CD40 ligand stimulates proinflammatory cytokine production by human endothelial cells. J Immunol 159 (1997) 5640-5647
6. Horton D.B., Libby P., and Schonbeck U. Ligation of CD40 on vascular smooth muscle cells mediates loss of interstitial collagen via matrix metalloproteinase activity. Ann N Y Acad Sci 947 (2001) 329-336
7. Schonbeck U., Mach F., Sukhova G.K., et al. CD40 ligation induces tissue factor expression in human vascular smooth muscle cells. Am J Pathol 156 (2000) 7-14
8. Mach F., Schonbeck U., Sukhova G.K., Atkinson E., and Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signaling. Nature 394 (1998) 200-203
9. Lutgens E., Gorelik L., Daemen M.J.A.P., et al. Requirement for CD154 in the progression of atherosclerosis. Nat Med 5 (1999) 1313-1316
10. Graf D., Muller S., Korthauer U., vanKooten C., Weise C., and Kroczek R.A. A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. Eur J Immunol 25 (1995) 1749-1754
11. Aukrust P., Muller F., Ueland T., et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 100 (1999) 614-620
12. Heeschen C., Dimmeler S., Hamm C.W., et al., CAPTURE Study Investigators. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 348 (2003) 1104-1111
13. Garlichs C.D., John S., Schmeisser A., et al. Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia. Circulation 104 (2001) 2395-2400
14. Cipollone F., Mezzetti A., Porreca E., et al. Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. Circulation 106 (2002) 399-402
15. Damas J.K., Otterdal K., Yndestad A., et al. Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells. Circulation 110 (2004) 999-1005
16. Varo N., Vicent D., Libby P., et al. Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones. Circulation 107 (2003) 2664-2669
17. Welch G.N., and Loscalzo J.N. Homocysteine and atherothrombosis. N Engl J Med 338 (1998) 1042-1050
18. Davi G., DiMinno G., Coppola A., et al. Oxidative stress and platelet activation in homozygous homocystinuria. Circulation 104 (2001) 1124-1128
19. Frosst P., Blom H.J., Milos R., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10 (1995) 111-113
20. Silverman M.D., Tumuluri R.J., Davis M., Lopez G., Rosenbaum J.T., and Lelkes P.I. Homocysteine upregulates vascular cell adhesion molecule-1 expression in cultured human aortic endothelial cells and enhances monocyte adhesion. Arterioscler Thromb Vasc Biol 22 (2002) 587-592
21. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest 98 (1996) 5-7
22. El-Khairy L., Ueland P.M., Refsum H., Graham I.M., Vollset S.E., and European Concerted Action Project. Plasma total cysteine as a risk factor for vascular disease: the European Concerted Action Project. Circulation 103 (2001) 2544-2549
23. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
24. Nannizzi-Alaimo L., Alves V.L., and Phillips D.R. Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation. Circulation 107 (2003) 1123-1128
25. Santilli F., Davi G., Consoli A., et al. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus. J Am Coll Cardiol 47 (2006) 391-397
26. Zeng X., Dai J., Remick D.G., and Wang X. Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes. Circ Res 93 (2003) 311-320
27. Au-Yeung K.K., Woo C.W., Sung F.L., Yip J.C., and Siow YL O.K. Hyperhomocysteinemia activates nuclear factor-kappa B in endothelial cells via oxidative stress. Circ Res 94 (2004) 28-36
28. Weiss N., Zhang Y.Y., Heydrick S., Bierl C., and Loscalzo J. Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction. Proc Natl Acad Sci U S A 98 (2001) 12503-12508
29. Urbich C., Dernbach E., Aicher A., Zeiher A.M., and Dimmeler S. CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species. Circulation 106 (2002) 981-986
30. Wagner A.H., Gebauer M., Pollok-Kopp B., and Hecker M. Cytokine-inducible CD40 expression in human endothelial cells is mediated by interferon regulatory factor-1. Blood 99 (2002) 520-525
31. Troen A.M., Lutgens E., Smith D.E., Rosenberg I.H., and Selhub J. The atherogenic effect of excess methionine intake. Proc Natl Acad Sci U S A 100 (2003) 15089-15094
32. Pfanzagl B., Tribl F., Koller E., and Moslinger T. Homocysteine strongly enhances metal-catalyzed LDL oxidation in the presence of cystine and cysteine. Atherosclerosis 168 (2003) 39-48